News

ARCHIVE

Day: November 20, 2018

Tetra Bio-Pharma Enters into Binding Proposal with Quantum Pharma Inc.

Tetra Bio-Pharma Inc. and Quantum Pharma Inc. today announced the signing of a binding proposal for exclusive access to a Health Canada licensed facility (i.e., Drug Establishment License; DEL) that enables the company to produce cannabis and cannabinoid drug products for Tetra’s and Panag Pharma’s development activities including the ocular drug formulations.

Read More »
Close Menu

STAY UPDATED.
GET THE LASTEST NEWS.